Inside the Trade: Addicted to Allergan

The Allergan-Valeant takeover saga may be long over, but there’s still some life left in the trade.

Illustration by The Project Twins

When the smoke finally cleared from the epic Allergan-Valeant takeover battle, everybody walked away richer, from Pershing Square Capital Management’s Bill Ackman to Och-Ziff Capital Management Group’s Dan Och to Paulson & Co.’s

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.